Doximity (DOCS) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Adjusted EPS
- $0.29
- Estimate
- $0.30
- Surprise
- -4.2%
- Revenue (period 2026-06-30)
- $156.6M
- Score at report (before → after)
- 5.9 → 5.9/10
Revenue source: xbrl.
How the report landed
Doximity (DOCS) missed the $0.30 estimate with adjusted EPS of $0.29 — a clear 4.2% shortfall. TrendMatrix's engine moved from Hold (5.9/10) to Sell at 5.9/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates DOCS Hold at 5.4/10.
2 of the last 4 quarters beat the estimate; this quarter's -4.2% surprise compares with a +2.4% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.2 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Analyst target reached - limited upside remaining
- Consecutive earnings misses (2)
- Weak growth
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $30.07
- Price target
- $30.59
- Stop
- $27.97
- Upside to target
- +1.7%
The stock trades at 35.9× trailing but 19.6× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 74 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-10-14 — shown for context, not personalized investment advice.
DOCS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $5.45B
- P/E (fwd)
- 19.6
- P/E (ttm)
- 35.9
- 52-week range
- $17.15–$71.37
- Off 52-week high
- 57.9%
- RSI (14)
- 74
- Volume vs avg
- 0.11×
- Score today
- 5.4/10